Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002472369 | SCV002769741 | likely benign | Rett syndrome | 2022-12-09 | reviewed by expert panel | curation | The allele frequency of the p.Pro176His variant in MECP2 (NM_004992.3) is 0.022% in Other sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro176His variant is observed in 1 unaffected individual (internal database) (BS2_supporting). In summary, the p.Pro176His variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BA1, BS2_supporting). |
Eurofins Ntd Llc |
RCV000678233 | SCV000230252 | uncertain significance | not provided | 2014-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317047 | SCV000850385 | likely benign | Inborn genetic diseases | 2017-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001472971 | SCV001677114 | likely benign | Severe neonatal-onset encephalopathy with microcephaly | 2023-11-05 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000678233 | SCV000804253 | uncertain significance | not provided | 2015-04-03 | no assertion criteria provided | clinical testing |